nodes	percent_of_prediction	percent_of_DWPC	metapath
Atomoxetine—HTR2A—narcolepsy	0.725	1	CbGaD
Atomoxetine—SLC6A2—locus ceruleus—narcolepsy	0.0143	0.127	CbGeAlD
Atomoxetine—HTR2A—enteric nervous system—narcolepsy	0.013	0.116	CbGeAlD
Atomoxetine—HTR2A—locus ceruleus—narcolepsy	0.00861	0.0764	CbGeAlD
Atomoxetine—SLC6A2—autonomic nervous system—narcolepsy	0.00761	0.0676	CbGeAlD
Atomoxetine—NPY1R—forebrain—narcolepsy	0.00522	0.0464	CbGeAlD
Atomoxetine—HTR2A—pons—narcolepsy	0.00496	0.044	CbGeAlD
Atomoxetine—HTR2A—autonomic nervous system—narcolepsy	0.00457	0.0406	CbGeAlD
Atomoxetine—HTR6—forebrain—narcolepsy	0.00368	0.0326	CbGeAlD
Atomoxetine—HTR1B—brainstem—narcolepsy	0.0023	0.0204	CbGeAlD
Atomoxetine—SLC6A3—brainstem—narcolepsy	0.00228	0.0202	CbGeAlD
Atomoxetine—HTR1D—brainstem—narcolepsy	0.00222	0.0197	CbGeAlD
Atomoxetine—HTR1B—forebrain—narcolepsy	0.00222	0.0197	CbGeAlD
Atomoxetine—HTR2C—brainstem—narcolepsy	0.0022	0.0195	CbGeAlD
Atomoxetine—SLC6A3—forebrain—narcolepsy	0.0022	0.0195	CbGeAlD
Atomoxetine—NPY1R—brain—narcolepsy	0.00217	0.0192	CbGeAlD
Atomoxetine—HTR1D—forebrain—narcolepsy	0.00215	0.0191	CbGeAlD
Atomoxetine—HTR2C—forebrain—narcolepsy	0.00212	0.0189	CbGeAlD
Atomoxetine—SLC6A4—brainstem—narcolepsy	0.00209	0.0185	CbGeAlD
Atomoxetine—SLC6A4—forebrain—narcolepsy	0.00201	0.0179	CbGeAlD
Atomoxetine—SLC6A2—brainstem—narcolepsy	0.00184	0.0163	CbGeAlD
Atomoxetine—SLC6A2—forebrain—narcolepsy	0.00177	0.0157	CbGeAlD
Atomoxetine—HTR2C—medulla oblongata—narcolepsy	0.00154	0.0136	CbGeAlD
Atomoxetine—HTR6—brain—narcolepsy	0.00153	0.0135	CbGeAlD
Atomoxetine—HTR1B—midbrain—narcolepsy	0.00146	0.013	CbGeAlD
Atomoxetine—SLC6A3—midbrain—narcolepsy	0.00145	0.0129	CbGeAlD
Atomoxetine—HTR1D—midbrain—narcolepsy	0.00142	0.0126	CbGeAlD
Atomoxetine—HTR2C—midbrain—narcolepsy	0.0014	0.0125	CbGeAlD
Atomoxetine—SLC6A4—midbrain—narcolepsy	0.00133	0.0118	CbGeAlD
Atomoxetine—SLC6A2—medulla oblongata—narcolepsy	0.00128	0.0114	CbGeAlD
Atomoxetine—HTR2A—brainstem—narcolepsy	0.0011	0.00981	CbGeAlD
Atomoxetine—HTR2A—forebrain—narcolepsy	0.00107	0.00946	CbGeAlD
Atomoxetine—CYP2D6—brainstem—narcolepsy	0.00101	0.00893	CbGeAlD
Atomoxetine—CYP2D6—forebrain—narcolepsy	0.000971	0.00862	CbGeAlD
Atomoxetine—HTR1B—brain—narcolepsy	0.00092	0.00816	CbGeAlD
Atomoxetine—SLC6A3—brain—narcolepsy	0.000912	0.0081	CbGeAlD
Atomoxetine—Pseudoephedrine—TNF—narcolepsy	0.000895	0.251	CrCbGaD
Atomoxetine—HTR1D—brain—narcolepsy	0.00089	0.0079	CbGeAlD
Atomoxetine—HTR2C—brain—narcolepsy	0.000882	0.00783	CbGeAlD
Atomoxetine—SLC6A4—brain—narcolepsy	0.000836	0.00742	CbGeAlD
Atomoxetine—Duloxetine—HTR2A—narcolepsy	0.000782	0.219	CrCbGaD
Atomoxetine—HTR2A—medulla oblongata—narcolepsy	0.00077	0.00684	CbGeAlD
Atomoxetine—SLC6A2—brain—narcolepsy	0.000736	0.00653	CbGeAlD
Atomoxetine—HTR2A—midbrain—narcolepsy	0.000704	0.00625	CbGeAlD
Atomoxetine—Fluoxetine—HTR2A—narcolepsy	0.000637	0.179	CrCbGaD
Atomoxetine—Maprotiline—HTR2A—narcolepsy	0.000595	0.167	CrCbGaD
Atomoxetine—HTR2A—brain—narcolepsy	0.000442	0.00393	CbGeAlD
Atomoxetine—CYP2D6—brain—narcolepsy	0.000403	0.00358	CbGeAlD
Atomoxetine—Nortriptyline—HTR2A—narcolepsy	0.000358	0.1	CrCbGaD
Atomoxetine—HTR2C—GPCR ligand binding—HCRTR2—narcolepsy	0.000321	0.00202	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR ligand binding—HCRTR1—narcolepsy	0.000321	0.00202	CbGpPWpGaD
Atomoxetine—HTR6—GPCR ligand binding—PENK—narcolepsy	0.000319	0.00201	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR ligand binding—PENK—narcolepsy	0.000316	0.00199	CbGpPWpGaD
Atomoxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.000312	0.00196	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR ligand binding—PENK—narcolepsy	0.00031	0.00195	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR ligand binding—P2RY11—narcolepsy	0.00031	0.00195	CbGpPWpGaD
Atomoxetine—HTR1D—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00031	0.00195	CbGpPWpGaD
Atomoxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.000308	0.00194	CbGpPWpGaD
Atomoxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.000307	0.00193	CbGpPWpGaD
Atomoxetine—HTR1B—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.000303	0.00191	CbGpPWpGaD
Atomoxetine—NPY1R—GPCR downstream signaling—TAC1—narcolepsy	0.000302	0.0019	CbGpPWpGaD
Atomoxetine—NPY1R—GPCR downstream signaling—NPS—narcolepsy	0.000302	0.0019	CbGpPWpGaD
Atomoxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.0003	0.00189	CbGpPWpGaD
Atomoxetine—Desipramine—HTR2A—narcolepsy	0.000294	0.0827	CrCbGaD
Atomoxetine—NPY1R—Signaling Pathways—HCRT—narcolepsy	0.000294	0.00185	CbGpPWpGaD
Atomoxetine—HTR2A—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.000289	0.00182	CbGpPWpGaD
Atomoxetine—SLC6A4—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.000289	0.00182	CbGpPWpGaD
Atomoxetine—HTR2C—G alpha (q) signalling events—TAC1—narcolepsy	0.000288	0.00181	CbGpPWpGaD
Atomoxetine—HTR2C—G alpha (q) signalling events—NPS—narcolepsy	0.000288	0.00181	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR ligand binding—HCRTR1—narcolepsy	0.000278	0.00175	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR ligand binding—HCRTR2—narcolepsy	0.000278	0.00175	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling by GPCR—NPS—narcolepsy	0.000274	0.00172	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling by GPCR—TAC1—narcolepsy	0.000274	0.00172	CbGpPWpGaD
Atomoxetine—HTR6—GPCR ligand binding—TRH—narcolepsy	0.000271	0.00171	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR ligand binding—P2RY11—narcolepsy	0.000269	0.00169	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR ligand binding—TRH—narcolepsy	0.000269	0.00169	CbGpPWpGaD
Atomoxetine—HTR2C—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.000268	0.00169	CbGpPWpGaD
Atomoxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.000268	0.00168	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR ligand binding—TRH—narcolepsy	0.000263	0.00166	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR ligand binding—HCRT—narcolepsy	0.000263	0.00166	CbGpPWpGaD
Atomoxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.000262	0.00165	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—PENK—narcolepsy	0.000262	0.00165	CbGpPWpGaD
Atomoxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000259	0.00163	CbGpPWpGaD
Atomoxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000259	0.00163	CbGpPWpGaD
Atomoxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.000257	0.00162	CbGpPWpGaD
Atomoxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.000257	0.00162	CbGpPWpGaD
Atomoxetine—HTR1D—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000257	0.00162	CbGpPWpGaD
Atomoxetine—HTR1D—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000257	0.00162	CbGpPWpGaD
Atomoxetine—HTR1B—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000251	0.00158	CbGpPWpGaD
Atomoxetine—HTR1B—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000251	0.00158	CbGpPWpGaD
Atomoxetine—HTR2A—G alpha (q) signalling events—TAC1—narcolepsy	0.00025	0.00157	CbGpPWpGaD
Atomoxetine—HTR2A—G alpha (q) signalling events—NPS—narcolepsy	0.00025	0.00157	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—HCRTR1—narcolepsy	0.000246	0.00155	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—HCRTR2—narcolepsy	0.000246	0.00155	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—HCRTR2—narcolepsy	0.000244	0.00154	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—HCRTR1—narcolepsy	0.000244	0.00154	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—HCRTR2—narcolepsy	0.000239	0.00151	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—HCRTR1—narcolepsy	0.000239	0.00151	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—P2RY11—narcolepsy	0.000238	0.0015	CbGpPWpGaD
Atomoxetine—HTR6—GPCR ligand binding—HRH3—narcolepsy	0.000238	0.0015	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—P2RY11—narcolepsy	0.000236	0.00148	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR ligand binding—HRH3—narcolepsy	0.000236	0.00148	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR ligand binding—PENK—narcolepsy	0.000235	0.00148	CbGpPWpGaD
Atomoxetine—HTR2A—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.000233	0.00147	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—P2RY11—narcolepsy	0.000231	0.00145	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR ligand binding—HRH3—narcolepsy	0.000231	0.00145	CbGpPWpGaD
Atomoxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00023	0.00145	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR ligand binding—HCRT—narcolepsy	0.000229	0.00144	CbGpPWpGaD
Atomoxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.000228	0.00143	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—HCRTR2—narcolepsy	0.000223	0.00141	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—HCRTR1—narcolepsy	0.000223	0.00141	CbGpPWpGaD
Atomoxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.000223	0.00141	CbGpPWpGaD
Atomoxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.000223	0.00141	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—TRH—narcolepsy	0.000223	0.0014	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—HCRTR2—narcolepsy	0.000222	0.0014	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—HCRTR1—narcolepsy	0.000222	0.0014	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—HCRTR1—narcolepsy	0.000217	0.00137	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—HCRTR2—narcolepsy	0.000217	0.00137	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—P2RY11—narcolepsy	0.000216	0.00136	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—P2RY11—narcolepsy	0.000214	0.00135	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—P2RY11—narcolepsy	0.00021	0.00132	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR ligand binding—PENK—narcolepsy	0.000204	0.00128	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—HCRT—narcolepsy	0.000202	0.00127	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—HCRT—narcolepsy	0.000201	0.00126	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR ligand binding—TRH—narcolepsy	0.0002	0.00126	CbGpPWpGaD
Atomoxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.0002	0.00126	CbGpPWpGaD
Atomoxetine—HTR6—GPCR ligand binding—NPS—narcolepsy	0.000197	0.00124	CbGpPWpGaD
Atomoxetine—HTR6—GPCR ligand binding—TAC1—narcolepsy	0.000197	0.00124	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—HCRT—narcolepsy	0.000196	0.00124	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR ligand binding—NPS—narcolepsy	0.000195	0.00123	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR ligand binding—TAC1—narcolepsy	0.000195	0.00123	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—HRH3—narcolepsy	0.000195	0.00123	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR ligand binding—TAC1—narcolepsy	0.000191	0.0012	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR ligand binding—NPS—narcolepsy	0.000191	0.0012	CbGpPWpGaD
Atomoxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00019	0.0012	CbGpPWpGaD
Atomoxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00019	0.0012	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—HCRT—narcolepsy	0.000184	0.00116	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—HCRT—narcolepsy	0.000182	0.00115	CbGpPWpGaD
Atomoxetine—HTR6—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000182	0.00114	CbGpPWpGaD
Atomoxetine—NPY1R—GPCR downstream signaling—HTR2A—narcolepsy	0.000181	0.00114	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—HCRTR2—narcolepsy	0.000181	0.00114	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—HCRTR1—narcolepsy	0.000181	0.00114	CbGpPWpGaD
Atomoxetine—HTR1D—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00018	0.00113	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—PENK—narcolepsy	0.00018	0.00113	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—PENK—narcolepsy	0.000179	0.00113	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—HCRT—narcolepsy	0.000178	0.00112	CbGpPWpGaD
Atomoxetine—HTR1B—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000176	0.00111	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—P2RY11—narcolepsy	0.000175	0.0011	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—PENK—narcolepsy	0.000175	0.0011	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR ligand binding—HRH3—narcolepsy	0.000175	0.0011	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR ligand binding—TRH—narcolepsy	0.000173	0.00109	CbGpPWpGaD
Atomoxetine—HTR2C—G alpha (q) signalling events—HTR2A—narcolepsy	0.000173	0.00109	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.000166	0.00104	CbGpPWpGaD
Atomoxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000165	0.00104	CbGpPWpGaD
Atomoxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000165	0.00104	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling by GPCR—HTR2A—narcolepsy	0.000165	0.00104	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—HCRTR1—narcolepsy	0.000165	0.00104	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—HCRTR2—narcolepsy	0.000165	0.00104	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—PENK—narcolepsy	0.000164	0.00103	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—PENK—narcolepsy	0.000162	0.00102	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—TAC1—narcolepsy	0.000162	0.00102	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—NPS—narcolepsy	0.000162	0.00102	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—PENK—narcolepsy	0.000159	0.001	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—P2RY11—narcolepsy	0.000159	0.001	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—HCRTR2—narcolepsy	0.000157	0.000991	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—HCRTR1—narcolepsy	0.000157	0.000991	CbGpPWpGaD
Atomoxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000156	0.000979	CbGpPWpGaD
Atomoxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.000155	0.000974	CbGpPWpGaD
Atomoxetine—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000154	0.000972	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—TRH—narcolepsy	0.000153	0.000964	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—P2RY11—narcolepsy	0.000152	0.000957	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—TRH—narcolepsy	0.000152	0.000957	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR ligand binding—HRH3—narcolepsy	0.000152	0.000957	CbGpPWpGaD
Atomoxetine—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000151	0.000951	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—TRH—narcolepsy	0.000149	0.000937	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—HCRT—narcolepsy	0.000149	0.000937	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR ligand binding—TAC1—narcolepsy	0.000145	0.000913	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR ligand binding—NPS—narcolepsy	0.000145	0.000913	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—HCRTR2—narcolepsy	0.000143	0.0009	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—HCRTR1—narcolepsy	0.000143	0.0009	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—TRH—narcolepsy	0.000139	0.000875	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—P2RY11—narcolepsy	0.000138	0.000869	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—TRH—narcolepsy	0.000138	0.000869	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—TRH—narcolepsy	0.000135	0.000851	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—HCRT—narcolepsy	0.000135	0.000851	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—HRH3—narcolepsy	0.000134	0.000845	CbGpPWpGaD
Atomoxetine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000134	0.000842	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—HRH3—narcolepsy	0.000133	0.000839	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—PENK—narcolepsy	0.000133	0.000835	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—HCRTR2—narcolepsy	0.000132	0.000831	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—HCRTR1—narcolepsy	0.000132	0.000831	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—HCRTR1—narcolepsy	0.000131	0.000825	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—HCRTR2—narcolepsy	0.000131	0.000825	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—HRH3—narcolepsy	0.000131	0.000821	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—HCRT—narcolepsy	0.000129	0.000813	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—HCRTR1—narcolepsy	0.000128	0.000807	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—HCRTR2—narcolepsy	0.000128	0.000807	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—P2RY11—narcolepsy	0.000128	0.000803	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—P2RY11—narcolepsy	0.000127	0.000796	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR ligand binding—NPS—narcolepsy	0.000126	0.000793	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR ligand binding—TAC1—narcolepsy	0.000126	0.000793	CbGpPWpGaD
Atomoxetine—SLC6A4—SIDS Susceptibility Pathways—TNF—narcolepsy	0.000124	0.000781	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—P2RY11—narcolepsy	0.000124	0.00078	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—HRH3—narcolepsy	0.000122	0.000768	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—HRH3—narcolepsy	0.000121	0.000762	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—PENK—narcolepsy	0.00012	0.000758	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—HRH3—narcolepsy	0.000119	0.000746	CbGpPWpGaD
Atomoxetine—HTR6—GPCR ligand binding—HTR2A—narcolepsy	0.000118	0.000746	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR ligand binding—HTR2A—narcolepsy	0.000118	0.00074	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—HCRT—narcolepsy	0.000117	0.000739	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—PENK—narcolepsy	0.000115	0.000725	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR ligand binding—HTR2A—narcolepsy	0.000115	0.000725	CbGpPWpGaD
Atomoxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000115	0.000721	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000113	0.00071	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—TRH—narcolepsy	0.000113	0.00071	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—TAC1—narcolepsy	0.000111	0.0007	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—NPS—narcolepsy	0.000111	0.0007	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—TAC1—narcolepsy	0.00011	0.000695	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—NPS—narcolepsy	0.00011	0.000695	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—HCRT—narcolepsy	0.000108	0.000682	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—TAC1—narcolepsy	0.000108	0.000681	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—NPS—narcolepsy	0.000108	0.000681	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—HCRT—narcolepsy	0.000108	0.000677	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—HCRT—narcolepsy	0.000105	0.000663	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—PENK—narcolepsy	0.000105	0.000658	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—TRH—narcolepsy	0.000102	0.000645	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—TAC1—narcolepsy	0.000101	0.000636	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—NPS—narcolepsy	0.000101	0.000636	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—TAC1—narcolepsy	0.0001	0.000631	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—NPS—narcolepsy	0.0001	0.000631	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—HRH3—narcolepsy	9.89e-05	0.000622	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—TAC1—narcolepsy	9.82e-05	0.000618	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—NPS—narcolepsy	9.82e-05	0.000618	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—TRH—narcolepsy	9.79e-05	0.000616	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—HTR2A—narcolepsy	9.74e-05	0.000613	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—HCRTR2—narcolepsy	9.72e-05	0.000612	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—HCRTR1—narcolepsy	9.72e-05	0.000612	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—PENK—narcolepsy	9.66e-05	0.000608	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—PENK—narcolepsy	9.59e-05	0.000604	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—PENK—narcolepsy	9.39e-05	0.000591	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—P2RY11—narcolepsy	9.39e-05	0.000591	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—HRH3—narcolepsy	8.98e-05	0.000565	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—TRH—narcolepsy	8.89e-05	0.00056	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR ligand binding—HTR2A—narcolepsy	8.72e-05	0.000549	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—HRH3—narcolepsy	8.59e-05	0.000541	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—HCRTR2—narcolepsy	8.44e-05	0.000531	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—HCRTR1—narcolepsy	8.44e-05	0.000531	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—TRH—narcolepsy	8.22e-05	0.000517	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—TAC1—narcolepsy	8.2e-05	0.000516	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—NPS—narcolepsy	8.2e-05	0.000516	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—P2RY11—narcolepsy	8.15e-05	0.000513	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—TRH—narcolepsy	8.15e-05	0.000513	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—TRH—narcolepsy	7.98e-05	0.000503	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—HCRT—narcolepsy	7.98e-05	0.000503	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—HRH3—narcolepsy	7.8e-05	0.000491	CbGpPWpGaD
Atomoxetine—HTR2A—SIDS Susceptibility Pathways—TNF—narcolepsy	7.47e-05	0.00047	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—TAC1—narcolepsy	7.44e-05	0.000468	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—NPS—narcolepsy	7.44e-05	0.000468	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—CHKB—narcolepsy	7.39e-05	0.000465	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—HRH3—narcolepsy	7.2e-05	0.000453	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—HRH3—narcolepsy	7.15e-05	0.00045	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—NPS—narcolepsy	7.12e-05	0.000448	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—TAC1—narcolepsy	7.12e-05	0.000448	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—PENK—narcolepsy	7.12e-05	0.000448	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—HRH3—narcolepsy	7e-05	0.000441	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—HCRT—narcolepsy	6.93e-05	0.000436	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—CHKB—narcolepsy	6.8e-05	0.000428	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—HTR2A—narcolepsy	6.69e-05	0.000421	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—HTR2A—narcolepsy	6.64e-05	0.000418	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—HTR2A—narcolepsy	6.51e-05	0.000409	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—TAC1—narcolepsy	6.46e-05	0.000407	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—NPS—narcolepsy	6.46e-05	0.000407	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—PENK—narcolepsy	6.18e-05	0.000389	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—HTR2A—narcolepsy	6.08e-05	0.000383	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—TRH—narcolepsy	6.05e-05	0.000381	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—HTR2A—narcolepsy	6.03e-05	0.00038	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—TAC1—narcolepsy	5.97e-05	0.000376	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—NPS—narcolepsy	5.97e-05	0.000376	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—NPS—narcolepsy	5.92e-05	0.000373	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—TAC1—narcolepsy	5.92e-05	0.000373	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—HTR2A—narcolepsy	5.91e-05	0.000372	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—TAC1—narcolepsy	5.8e-05	0.000365	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—NPS—narcolepsy	5.8e-05	0.000365	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—HRH3—narcolepsy	5.31e-05	0.000334	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—TRH—narcolepsy	5.25e-05	0.000331	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—CPT1B—narcolepsy	5.02e-05	0.000316	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—HTR2A—narcolepsy	4.93e-05	0.00031	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—CPT1B—narcolepsy	4.62e-05	0.000291	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—HRH3—narcolepsy	4.61e-05	0.00029	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—HTR2A—narcolepsy	4.48e-05	0.000282	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—CHKB—narcolepsy	4.45e-05	0.00028	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—TAC1—narcolepsy	4.4e-05	0.000277	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—NPS—narcolepsy	4.4e-05	0.000277	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—TAC1—narcolepsy	3.82e-05	0.00024	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—NPS—narcolepsy	3.82e-05	0.00024	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—HTR2A—narcolepsy	3.59e-05	0.000226	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—HTR2A—narcolepsy	3.56e-05	0.000224	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—HTR2A—narcolepsy	3.49e-05	0.00022	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—CPT1B—narcolepsy	3.02e-05	0.00019	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—HTR2A—narcolepsy	2.64e-05	0.000166	CbGpPWpGaD
